The phrase "a low donor" is correct and usable in written English.
It can be used in contexts discussing contributions, such as financial donations or blood donations, where the amount or level of contribution is being described as low.
Example: "In our fundraising efforts, we have identified a group of low donors who may need additional encouragement to increase their contributions."
Alternatives: "minimal donor" or "small contributor".
It has a low donor site morbidity if FTSG is used.
A low donor:integrase plasmid ratio was used to minimize the contribution of random integrants to our colony counts.
Quadriceps tendon grafts are currently considered only a second choice graft, although clinical studies have demonstrated good results and a low donor site morbidity [ 1- 5].
Probes that are free in solution transfer energy from the donor fluorophore to the acceptor, resulting in a low donor fluorescence signal (and/or FRET emission of the acceptor).
It was later revealed to be a stunt to draw attention to the country's low donor numbers, a move similar to Britain's own Come On Down and Out, Kudos/Channel 4's satirical gameshow featuring homeless people (in fact actors) competing for a house in front of a duped studio audience.
A solvent dependence study revealed that the stabilisation of the radical cation intermediate, 1+, towards further oxidation is achieved in solvents with a low Gutmann donor number such as dichloromethane.
In vitro brain slice uptake studies clearly demonstrated a linear relationship between 125I-Aβ40 uptate at very low donor concentrations (5 ng/ml) and the uptake at higher donor concentrations of 450 or even 900 ng/ml (Figure 2I).
Quadriceps tendon grafts have been shown to provide good strength and low donor site morbidity, therefore being an alternative to hamstring grafts even in primary ACL reconstruction [ 5, 11, 12].
Results: The lateral upper arm flap showed low donor site morbidity, primary closure was achieved in all but one case.
In summary, low donor chimerism levels are associated with relapse and mortality and can potentially be used as an early predictive and prognostic marker.
Because many charities have low donor retention rates, he argued, "they would be far better off just communicating directly to their current donors and letting them know how previous donations made a difference".
